CD86 and neoplasm: Interestingly, this seemed to be accompanied by an increased activation of DCs across tissues, as identified by the upregulation of the co‐stimulatory molecule CD86 on surface of DCs in the skin drLN, spleen, and tumour (Figure S5D).